Reasons why everyone is losing on CANB - EVERYONE
As the only publicly traded company in America growing and processing hemp for CBD Isolate and selling a full lineup of CBD Isolate products, CANB is best positioned to deliver a windfall to its investors in 2019 due to the FDA approving CBD Isolate in dietary supplements for national sales
Mile High Labs and Medterra are two of the biggest CBD Isolate and CBD Isolate product companies, respectively in America and both are wildly successful, but neither one is publicly traded, so where else can an investor gain exposure to CBD Isolate and CBD Isolate products besides CANB?
Being the only CBD Oil stock utilizing the formulation of CBD most likely to be federally legalized by the FDA is certainly the most obvious advantage that CANB has over the rest of the sector
But there are several other advantages that CANB possesses, and perhaps the following favorable factors are acting synergistically with CANB’s CBD Isolate formulation to make it the top performing CBD Oil stock in September
1. Best financing in the sector
Private Placement at zero discount to market in August (restricted shares)
$4,000,000 raised at $.029
2. Most rapid annual revenue growth in the sector
500% revenue growth year-over-year
3. Only processor of raw hemp into CBD Isolate (as opposed to Full Spectrum CBD)
That is a unique advantage because CBD Isolate Processing is a huge market, there’s a tremendous lack of processors, and as has already been stated, CBD Isolate is the formulation most likely to receive FDA approval for national sales
So CANB is a baby Mile High Labs
4. Complete vertical integration from seed to sale
CANB is also a grower of hemp as well, so they have achieved complete vertical integration and full control over the entire supply chain from seed to sale, thereby maximizing profit margins
5. Medical Sales
CANB sells to both the retail and medical markets, but they specialize in the sales of CBD Oil products to the medical & healthcare community, which is a far less crowded market
6. Medical Devices with CBD
Another unique differentiator which is generating excellent revenue
7. % Gain Potential from Current Price
Lower priced stocks offer more leverage and % gain potential
It is easier for a stock like CANB to move 500% and hit $.10+ in comparison to the other CBD Oil stocks achieving 500% gains
